Medication info

Megasimvastatin Tablets (Simvastatin)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
L & C Bio Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202001045 · Approved 2020.02.17

This product's status changed to Approval withdrawn on 2024.07.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients taking this medicine before and during treatment must follow a standard cholesterol-lowering diet. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) For the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see the information below (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Results of controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start treatment at 5 mg daily and monitor carefully.
Child dose
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended starting dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
L & C Bio Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • hyperlipidemia
  • primary hypercholesterolemia
  • dyslipidemia
  • abetalipoproteinemia
  • high triglyceridemia
  • homozygous familial hypercholesterolemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of death from coronary heart disease, as well as the risk of non-fatal myocardial infarction and stroke, in adult patients who are at high risk of cardiovascular disease. It also reduces the risk of complications after vascular surgery and is used to treat various types of hyperlipidemia. It is particularly used as an adjunct to diet in children with heterozygous familial hypercholesterolemia who have a family history or other risk factors. It effectively lowers total cholesterol and LDL cholesterol levels while increasing HDL cholesterol, improving cardiovascular health. This medication is effectively used for the treatment and prevention of heart disease and dyslipidemia.

How to take

Adult dose

Patients taking this medicine before and during treatment must follow a standard cholesterol-lowering diet. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) For the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see the information below (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Results of controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start treatment at 5 mg daily and monitor carefully.

Child dose

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended starting dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication is used to lower blood cholesterol levels. Caution is needed as muscle-related side effects such as muscle pain or weakness may occur during use. Particularly, if taken at high doses or in combination with other specific medications, the risk of muscle damage may increase. Patients with liver disease or abnormal liver function test results should not take this medication as it can affect liver function. Women who are pregnant or may become pregnant and breastfeeding women should not take this medication. This medication may interact with certain antifungal drugs, antibiotics, and immunosuppressants, increasing the risk of muscle damage when taken together, so consultation with a physician is necessary. Special attention is required for the elderly, patients with impaired kidney function, and those with hypothyroidism. If unexplained muscle pain, tenderness, or weakness occurs during use, patients should inform their doctors immediately, and if symptoms are severe, they should discontinue the medication. Symptoms indicating liver function abnormalities or allergic reactions should also prompt immediate consultation with healthcare professionals. This medication is not recommended for children under 10 years old, and adolescents aged 10 and older should take it under the guidance of a physician. It is advisable to avoid taking this medication with certain foods such as grapefruit juice. This medication must be taken strictly according to a physician's prescription and instructions, and patients should inform other physicians about taking this medication when receiving treatment.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • indigestion
  • bloating
  • nausea
  • headache
Show 83 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramp
  • arthralgia
  • taste disturbance
  • ocular movement disorder
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmare
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • drug rash resembling lichen planus
  • gynecomastia
  • reduced libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • pancreatitis
  • loss of appetite
  • vomiting
  • liver failure
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • thrombocytopenia
  • peripheral nerve disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture, and it is best kept at temperatures between 1 degree to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.